As radiotherapy is a treatment modality commonly used for the treatment of metastatic and relapsed Ewing sarcoma (27–29) and is known to promote latent TGFβ activation, we also investigate the impact of TGFβ inhibition specifically during radiotherapy. Here, TGFB1 is linked to Ewing sarcoma.